Anthos Therapeutics

Anthos Therapeutics

Biotechnology, 55 Cambridge Pkwy, Cambridge, , 2142, Massachusetts, United States, 11-50 Employees

anthostherapeutics.com

  • facebook
  • LinkedIn

Who is ANTHOS THERAPEUTICS

Anthos Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of genetically and pharmacologically validated innovative therapies to a...

Read More

map
  • 55 Cambridge Pkwy, Cambridge, Massachusetts, 2142, United States Headquarters: 55 Cambridge Pkwy, Cambridge, Massachusetts, 2142, United States
  • 2018 Date Founded: 2018
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2833 | NAICS Code: 325411 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ANTHOS THERAPEUTICS

Anthos Therapeutics Org Chart and Mapping

Employees

Bruce Hug

Vice President, Clinical Development

Michael Doremus

Head of Technical Operations

Lynn Mallett

V.P. / Head of Finance, Corporate Treasurer

Sarah Bird

Contract Global Clinical Development Professional

Deb Freedholm

Vice President Operations

Jessica Seabrook

Operations/Communications

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Anthos Therapeutics

Answer: Anthos Therapeutics's headquarters are located at 55 Cambridge Pkwy, Cambridge, , 2142, Massachusetts, United States

Answer: Anthos Therapeutics's official website is https://anthostherapeutics.com

Answer: Anthos Therapeutics's revenue is $25 Million to $50 Million

Answer: Anthos Therapeutics's SIC: 2833

Answer: Anthos Therapeutics's NAICS: 325411

Answer: Anthos Therapeutics has 11-50 employees

Answer: Anthos Therapeutics is in Biotechnology

Answer: Anthos Therapeutics contact info: Phone number: Website: https://anthostherapeutics.com

Answer: Anthos Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of genetically and pharmacologically validated innovative therapies to advance care for people living with cardiovascular and metabolic (CVM) diseases. Anthos Therapeutics aims to combine the agility of a biotech with the rigor of a large pharmaceutical company. Anthos Therapeutics was launched by Blackstone Life Sciences in 2019.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access